Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Oncomed PharmaceuticalsAkari TherapeuticsAerpio PharmaceuticalsOncolytics BiotechVIVUS
SymbolNASDAQ:OMEDNASDAQ:AKTXOTCMKTS:ARPONASDAQ:ONCYNASDAQ:VVUS
Price Information
Current Price$0.89$1.73$0.67$0.5999$4.32
52 Week RangeHoldBuyHoldBuyN/A
Analyst Ratings
Consensus RecommendationHoldBuyHoldBuyN/A
Consensus Price Target$1.75$7.00$6.3333N/AN/A
% Upside from Price Target96.63% upside304.62% upside845.27% upsideN/AN/A
Trade Information
Market Cap$34.43 million$28.23 million$27.19 million$15.24 million$42.36 million
Beta1.86-2.81N/A2.051.83
Average Volume768,9042,100,384306,043399,017209,962
Sales & Book Value
Annual Revenue$44.42 millionN/AN/AN/A$65.06 million
Price / Sales0.78N/AN/AN/A0.71
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$1.25 per share$0.20 per shareN/A$0.11 per share($4.93) per share
Price / Book0.71N/AN/AN/A-0.88
Profitability
Net Income$-8,100,000.00$-16,470,000.00N/A$-13,140,000.00$-36,950,000.00
EPS($0.16)($0.17)N/A($0.82)($3.48)
Trailing P/E RatioN/A0.000.000.000.00
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-18.24%N/AN/AN/A-37.95%
Return on Equity (ROE)-13.14%-369.81%N/A-297.02%N/A
Return on Assets (ROA)-7.73%-152.87%N/A-113.65%-9.33%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/A0.08%N/A
Current Ratio5.04%1.13%N/A3.21%0.69%
Quick Ratio5.04%1.13%N/A3.21%0.56%
Ownership Information
Institutional Ownership Percentage45.16%15.26%0.37%1.03%15.10%
Insider Ownership Percentage20.32%61.80%38.60%0.10%12.00%
Miscellaneous
Employees2217N/AN/A57
Shares Outstanding38.69 million15.86 million40.59 million24.98 million10.64 million
Next Earnings DateN/A8/30/2019 (Estimated)N/A11/11/2019 (Estimated)11/7/2019 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableOptionable
 Oncomed PharmaceuticalsAkari TherapeuticsAerpio PharmaceuticalsOncolytics BiotechVIVUS

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel